| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC3594 | ncx-2057 | Novel NO-donor, suppressing inflammatory and nociceptive responses |
|
| DCC3595 | Ncx-6560 | Novel HMG-CoA reductase inhibitor and nitric oxide donor |
|
| DCC3596 | N-cyano-sch-12679 Bromide | Cyanogen Bromide adduct of (R)-SCH-12679, a D1 antagonist |
|
| DCC3597 | Levomepromazine Maleate | Tricyclic antidepressant (TCA), acting as a serotonin–norepinephrine reuptake inhibitor (SNRI) and also having other activities including antihistamine, antiadrenergic, antiserotonergic, anticholinergic, and sodium channel-blocking effects |
|
| DCC3598 | Nd1-yl2 | Novel degrader of steroid receptor co-activator 1 (SRC-1) |
|
| DCC3599 | Nd-2110 | Novel potent and highly specific IRAK4 inhibitor |
|
| DCC3600 | Nd-322 Hydrochloride | Selective water-soluble gelatinase inhibitor |
|
| DCC3601 | Nd-364 | Potent and selective inhibitor for gelatinases, matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MPP9) |
|
| DCC3602 | nd7001 | Inhibitor of Phosphodiesterase (PDE)-2 |
|
| DCC3603 | N-demethyldiltiazem | Precursor for radiolabeled diltiazem |
|
| DCC3604 | N-desmethyl Loperamide | Major metabolite of loperamide, also used as the precusor for radiolabelled loperamide |
|
| DCC3605 | Ndi-10 | Novel G4-DNA ligand, promoting transcription in Gram-positive bacteria and repressing transcription in Gram-negatives |
|
| DCC3606 | Ndm-1 Inhibitor-2 | Novel Inhibitor of New Delhi Metallo-β-lactamase-1 (NDM-1) |
|
| DCC3607 | nec-1i | Negative control compound for Necrostatin-1 related assays |
|
| DCC3608 | necrostatin-21 | Novel necroptosis inhibitor |
|
| DCC3609 | necrox-18 | Novel inhibitor of caspase-independent cell death with necrotic morphol, distinctly different from apoptosis, autophagy, and necroptosis, displaying strong mitochondrial reactive oxygen species and ONOO- scavenging activity |
|
| DCC3610 | Nefopam | Non-narcotic analgesic for the relief of acute and chronic pain |
|
| DCC3611 | Neil1-in-p2 | Novel Inhibitor of DNA Glycosylases, inhibiting NEIL1 activity |
|
| DCC3612 | Nek2/7-in-51 | Novel ATP-competitive inhibitor of Nek2 and Nek7 |
|
| DCC3613 | Neobractatin | Natural inhibitor of tumor metastasis by upregulating the RNA-binding-protein MBNL2, inducing cell cycle arrest through multiple signaling pathways including RNA binding protein CELF6 |
|
| DCC3614 | neocryptolepine | Inhibitor of the formation of |
|
| DCC3615 | Neothalfine | Potent natural anti-tumor agent against metastatic colorectal cancer, resulting in cell cycle arrest at the G2/M phase and inducing apoptosis through the dysfunction of mitochondria to trigger intrinsic apoptotic pathway by untargeted metabolomic method, |
|
| DCC3616 | Nepetin [520-11-6] | Natural inducer of autophagy and apoptosis, inhibiting glutamate overexcitation and upregulation of the Wnt/β-catenin signaling pathway |
|
| DCC3617 | Neq0502 | Novel AR inhibitor, being selective for the testosterone stimulated AR-dependent prostate cancer cell |
|
| DCC3618 | neq135 | The first potent NAD-driven small molecular inhibitor of TcGAPDH (Trypanosoma cruzi glyceraldehyde 3-phosphate dehydrogenase) |
|
| DCC3619 | nequimed176 | Novel non-peptidic, non-covalent cruzain inhibitor |
|
| DCC3620 | Nesiritide Acetate | Human B-type natriuretic peptide, facilitating cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldosterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation |
|
| DCC3621 | Nestifylline | Anti-inflammatory, antibronchospastic agent |
|
| DCC3622 | Netarsudil Mesylate | Novel dual Rho Kinase and norepinephrine transporter (ROCK/NET) inhibitor |
|
| DCC3623 | Net-c343 | Novel fluorescent RXR antagonist |
|
